HLS Therapeutics (HLS) Stock Chart & Stock Price History → 😱 This phenomenon is smashing regular market gains (From MillPub) (Ad) Free HLS Stock Alerts C$4.65 0.00 (0.00%) (As of 04/30/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades HLS Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance+17.13%3 Month Performance+12.05%6 Month Performance-4.91%Year-To-Date Performance+17.72%1 Year Performance-16.37% Receive HLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. HLS Stock Chart for Thursday, May, 2, 2024 HLS Chart by TradingView HLS Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2024C$4.65C$4.65C$4.65C$4.655,000 shsC$148.43 million04/30/2024C$4.65C$4.65C$4.65C$4.655,000 shsC$148.43 million04/29/2024C$4.65C$4.65C$4.66C$4.40700 shsC$148.43 million04/26/2024C$4.73C$4.65-1.69%C$4.66C$4.40700 shsC$148.43 million04/25/2024C$4.75C$4.73-0.42%C$4.75C$4.724,512 shsC$150.98 million04/24/2024C$4.75C$4.75C$4.75C$4.743,900 shsC$151.62 million Get the Latest News and Ratings for HLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/23/2024C$4.75C$4.75C$4.75C$4.752,000 shsC$151.62 million04/22/2024C$4.95C$4.75-4.04%C$4.95C$4.604,554 shsC$151.62 million04/19/2024C$4.92C$4.95+0.61%C$4.95C$4.95400 shsC$158.00 million04/18/2024C$4.89C$4.92+0.61%C$4.92C$4.90601 shsC$157.05 million04/17/2024C$4.89C$4.89C$5.01C$4.895,800 shsC$156.09 million04/16/2024C$4.94C$4.89-1.01%C$5.01C$4.895,800 shsC$156.09 million04/15/2024C$5.17C$4.94-4.45%C$5.11C$4.936,704 shsC$157.69 million04/12/2024C$5.01C$5.17+3.19%C$5.43C$5.0523,666 shsC$165.03 million04/11/2024C$5.13C$5.01-2.34%C$5.14C$5.013,000 shsC$159.92 million04/10/2024C$4.99C$5.13+2.81%C$5.15C$4.9912,678 shsC$163.75 million04/09/2024C$5.04C$4.99-0.99%C$5.34C$4.9716,630 shsC$159.28 million04/08/2024C$4.59C$5.04+9.80%C$5.48C$4.8119,754 shsC$160.88 million04/05/2024C$4.30C$4.59+6.74%C$4.72C$4.269,610 shsC$146.51 million04/04/2024C$4.17C$4.30+3.12%C$4.39C$4.184,584 shsC$137.26 million04/03/2024C$3.97C$4.17+5.04%C$4.30C$4.078,400 shsC$133.11 million04/02/2024C$4.06C$3.97-2.22%C$4.00C$3.978,818 shsC$126.72 million04/01/2024C$4.00C$4.06+1.50%C$4.31C$3.9910,105 shsC$129.60 million03/29/2024C$4.00C$4.00C$4.00C$3.678,600 shsC$127.68 million03/28/2024C$3.62C$4.00+10.50%C$4.00C$3.678,600 shsC$127.68 million03/27/2024C$3.61C$3.62+0.28%C$3.62C$3.601,300 shsC$115.55 million03/26/2024C$3.68C$3.61-1.90%C$3.75C$3.52132,900 shsC$115.23 million03/25/2024C$3.84C$3.68-4.17%C$3.85C$3.689,475 shsC$117.47 million03/22/2024C$3.95C$3.84-2.78%C$4.03C$3.8138,340 shsC$122.57 million03/21/2024C$3.95C$3.95C$4.00C$3.9224,901 shsC$126.08 million03/20/2024C$4.05C$3.95-2.47%C$4.02C$3.9325,280 shsC$126.08 million03/19/2024C$4.02C$4.05+0.75%C$4.10C$4.003,200 shsC$129.28 million03/18/2024C$4.00C$4.02+0.50%C$4.13C$4.0212,630 shsC$128.32 million03/15/2024C$3.99C$4.00+0.25%C$4.15C$3.9913,525 shsC$128.28 million03/14/2024C$4.34C$3.99-8.06%C$4.41C$3.9363,970 shsC$127.96 million03/13/2024C$4.28C$4.34+1.40%C$4.44C$4.204,903 shsC$139.18 million03/12/2024C$4.21C$4.28+1.66%C$4.50C$4.203,343 shsC$137.26 million03/11/2024C$4.21C$4.21C$4.25C$4.2010,499 shsC$135.02 million03/08/2024C$4.23C$4.21-0.47%C$4.25C$4.2010,500 shsC$135.02 million03/07/2024C$4.21C$4.23+0.48%C$4.26C$4.215,682 shsC$135.66 millionThe biggest energy story ever? (Ad)Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…For the full story, click here.03/06/2024C$4.29C$4.21-1.86%C$4.39C$4.213,967 shsC$135.02 million03/05/2024C$4.17C$4.29+2.88%C$4.40C$4.116,762 shsC$137.58 million03/04/2024C$4.20C$4.17-0.71%C$4.17C$4.124,595 shsC$133.73 million03/01/2024C$4.18C$4.20+0.48%C$4.24C$4.17900 shsC$134.69 million02/29/2024C$4.00C$4.18+4.50%C$4.20C$4.1513,700 shsC$134.05 million02/28/2024C$3.98C$4.00+0.50%C$4.03C$3.972,656 shsC$128.28 million02/27/2024C$3.78C$3.98+5.29%C$3.98C$3.759,297 shsC$127.64 million02/26/2024C$3.98C$3.78-5.03%C$3.99C$3.683,500 shsC$121.23 million02/23/2024C$4.05C$3.98-1.73%C$3.98C$3.98100 shsC$127.64 million02/22/2024C$4.11C$4.05-1.46%C$4.12C$4.055,377 shsC$129.88 million02/21/2024C$4.11C$4.11C$4.12C$4.11300 shsC$131.81 million02/20/2024C$4.12C$4.11-0.24%C$4.11C$4.111,115 shsC$131.81 million02/19/2024C$4.12C$4.12C$4.14C$4.10500 shsC$132.13 million02/16/2024C$4.05C$4.12+1.73%C$4.14C$4.10500 shsC$132.13 million02/15/2024C$4.01C$4.05+1.00%C$4.07C$4.021,000 shsC$129.88 million02/14/2024C$4.01C$4.01C$4.01C$4.01100 shsC$128.60 million02/13/2024C$4.16C$4.01-3.61%C$4.15C$4.004,600 shsC$128.60 million02/12/2024C$4.14C$4.16+0.48%C$4.16C$4.06500 shsC$133.41 million02/09/2024C$4.15C$4.14-0.24%C$4.21C$4.145,100 shsC$132.77 million02/08/2024C$4.15C$4.15C$4.16C$4.152,900 shsC$133.09 million02/07/2024C$4.25C$4.15-2.35%C$4.16C$4.152,900 shsC$133.09 million02/06/2024C$4.28C$4.25-0.70%C$4.26C$4.0012,070 shsC$136.30 million02/05/2024C$4.15C$4.28+3.13%C$4.28C$4.156,138 shsC$137.26 million02/02/2024C$4.15C$4.15C$4.29C$4.1511,800 shsC$133.09 million02/01/2024C$4.15C$4.15C$4.29C$4.1511,800 shsC$133.09 million Related Companies: Cardiol Therapeutics Stock Chart BioSyent Stock Chart Cipher Pharmaceuticals Stock Chart Decibel Cannabis Stock Chart Organigram Stock Chart Charlotte's Web Stock Chart Aurora Cannabis Stock Chart Knight Therapeutics Stock Chart Zentek Stock Chart Sernova Stock Chart Receive HLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:HLS) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace😱 This phenomenon is smashing regular market gainsMillPubA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
